X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (122) 122
Publication (14) 14
Newspaper Article (3) 3
Patent (2) 2
Book Chapter (1) 1
Book Review (1) 1
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (62) 62
index medicus (51) 51
male (46) 46
female (36) 36
middle aged (32) 32
adult (29) 29
aged (25) 25
oncology (24) 24
animals (20) 20
dermatology (17) 17
health aspects (17) 17
research (17) 17
medicine & public health (16) 16
cancer (15) 15
risk factors (14) 14
care and treatment (12) 12
patients (12) 12
adolescent (11) 11
psoriasis (11) 11
analysis (10) 10
chemotherapy (10) 10
internal medicine (10) 10
research article (10) 10
treatment outcome (10) 10
aged, 80 and over (9) 9
infectious diseases (9) 9
medicine (9) 9
therapy (9) 9
breast cancer (8) 8
infections (8) 8
breast neoplasms - pathology (7) 7
expression (7) 7
genetic aspects (7) 7
mice (7) 7
parasites (7) 7
prognosis (7) 7
retrospective studies (7) 7
surgery (7) 7
survival (7) 7
breast neoplasms - drug therapy (6) 6
diagnosis (6) 6
disease-free survival (6) 6
double-blind (6) 6
drug therapy (6) 6
epidemiology (6) 6
hematology (6) 6
insects (6) 6
italy - epidemiology (6) 6
management (6) 6
medical research (6) 6
metastasis (6) 6
neurosciences (6) 6
physiological aspects (6) 6
prospective studies (6) 6
protozoa (6) 6
skin - pathology (6) 6
studies (6) 6
tropical medicine (6) 6
young adult (6) 6
antineoplastic agents - therapeutic use (5) 5
behavior (5) 5
chagas' disease (5) 5
child (5) 5
confocal microscopy (5) 5
dermatology & venereal diseases (5) 5
gene expression (5) 5
kinetics (5) 5
lesions (5) 5
metastatic breast cancer (5) 5
mortality (5) 5
multidisciplinary sciences (5) 5
neoplasm metastasis (5) 5
parasitology (5) 5
public health (5) 5
rhodnius - parasitology (5) 5
trypanosoma cruzi (5) 5
tumors (5) 5
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
arctic medicine. tropical medicine (4) 4
cancer patients (4) 4
cancer research (4) 4
cancer therapies (4) 4
clinical neurology (4) 4
combined modality therapy (4) 4
cross-sectional studies (4) 4
cyclophosphamide (4) 4
disease (4) 4
efficacy (4) 4
fungi (4) 4
immunohistochemistry (4) 4
infection (4) 4
insect vectors - parasitology (4) 4
kaplan-meier estimate (4) 4
magnetic resonance imaging (4) 4
medical prognosis (4) 4
medicine, experimental (4) 4
metastases (4) 4
neoadjuvant chemotherapy (4) 4
neoplasm staging (4) 4
outcomes (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 7/2010, Volume 122, Issue 1, pp. 181 - 188
Long-term bisphosphonate therapy is associated with increased risk of osteonecrosis of the jaw (ONJ). In a retrospective analysis, a 16% ONJ incidence was... 
Angiogenesis | Bisphosphonate | Medicine & Public Health | Osteonecrosis of the jaw | Oncology | Metastatic breast cancer | Bevacizumab | MULTIPLE-MYELOMA | RISK-FACTORS | EFFICACY | BONE METASTASES | PREVENTION | ONJ | ONCOLOGY | PROSTATE-CANCER | ENDOTHELIAL GROWTH-FACTOR | Prospective Studies | Osteonecrosis - epidemiology | Humans | Jaw Diseases - prevention & control | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Antineoplastic Agents - therapeutic use | Vinblastine - administration & dosage | Incidence | Jaw Diseases - chemically induced | Antibodies, Monoclonal, Humanized | Angiogenesis Inhibitors - administration & dosage | Neoplasm Metastasis | Vinblastine - analogs & derivatives | Antineoplastic Agents - adverse effects | Angiogenesis Inhibitors - therapeutic use | Female | Paclitaxel - administration & dosage | Angiogenesis Inhibitors - adverse effects | Diphosphonates - adverse effects | Multicenter Studies as Topic - statistics & numerical data | Randomized Controlled Trials as Topic - statistics & numerical data | Double-Blind Method | Jaw Diseases - epidemiology | Breast Neoplasms - drug therapy | Oral Hygiene | Drug Synergism | Breast Neoplasms - complications | Taxoids - administration & dosage | Breast Neoplasms - genetics | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Genes, erbB-2 | Aged | Osteonecrosis - chemically induced | Osteonecrosis - prevention & control | Care and treatment | Analysis | Phosphonates | Clinical trials | Bones | Breast cancer | Angiogenesis inhibitors | Health aspects | Necrosis
Journal Article
Journal Article
Breast Cancer Research, ISSN 1465-5411, 06/2018, Volume 20, Issue 1, pp. 62 - 10
Background: Tumor-infiltrating lymphocytes (TILs) evaluated in primary breast cancer (BC) convey prognostic information. Limited data in the metastatic setting... 
PD-L1 | Metastatic breast cancer | Tumor-infiltrating lymphocytes | HER2 | Triple negative | TRASTUZUMAB | FREE SURVIVAL | DOCETAXEL | CHEMOTHERAPY | TRIAL | RESPIRATORY SYSTEM | DISEASE | TILS | Research | Metastasis | Biological markers
Journal Article
PLOS ONE, ISSN 1932-6203, 04/2019, Volume 14, Issue 4, p. e0214884
Panniculitis and vitiligo-like lesions have been recently identified as rare cutaneous side effects of the combination of BRAF and MEK inhibitors, a standard... 
V600-MUTANT METASTATIC MELANOMA | DABRAFENIB | SURVIVAL | TRAMETINIB | MULTIDISCIPLINARY SCIENCES | POOLED ANALYSIS | OUTCOMES | VEMURAFENIB | Skin Neoplasms - drug therapy | Oximes - adverse effects | Humans | Middle Aged | Oximes - administration & dosage | Imidazoles - administration & dosage | Male | Antineoplastic Agents - administration & dosage | Protein Kinase Inhibitors - adverse effects | Pyridones - administration & dosage | Antineoplastic Agents - adverse effects | Melanoma - genetics | Skin Neoplasms - mortality | Adult | Female | Retrospective Studies | Vitiligo - chemically induced | Imidazoles - adverse effects | Pyrimidinones - adverse effects | Kaplan-Meier Estimate | Antineoplastic Combined Chemotherapy Protocols | Treatment Outcome | Proto-Oncogene Proteins B-raf - antagonists & inhibitors | Panniculitis - chemically induced | Protein Kinase Inhibitors - administration & dosage | MAP Kinase Signaling System - drug effects | Vitiligo - pathology | Proto-Oncogene Proteins B-raf - genetics | Melanoma - drug therapy | Progression-Free Survival | Skin Neoplasms - genetics | Aged | Pyrimidinones - administration & dosage | Mutation | Panniculitis - pathology | Pyridones - adverse effects | Melanoma - mortality | Gene mutations | Panniculitis | Genetic aspects | Research | Drug therapy, Combination | Drug therapy | Risk factors | Therapy | Antigens | Dermatology | Pathogenesis | MEK inhibitors | Melanoma | Health risks | Oncology | Metastasis | Multivariate analysis | Cancer therapies | Patients | Survival | Metastases | Side effects | Vitiligo | Inhibitors | Risk assessment | Medical prognosis | Skin diseases | Skin | Lesions | Public health
Journal Article
by Bellelli, Giuseppe and Morandi, Alessandro and Mazzone, Andrea and Cherubini, Antonio and Mossello, Enrico and Bo, Mario and Bianchetti, Angelo and Rozzini, Renzo and Zanetti, Ermellina and Musicco, Massimo and Ferrari, Alberto and Ferrara, Nicola and Trabucchi, Marco and Boffelli, Stefano and Stefano, Fabio Di and Filippi, Francesco De and Guerini, Fabio and Bertoletti, Erik and March, Albert and Margiotta, Alessandro and Mecocci, Patrizia and Addesi, Desireè and Dijik, Babette and Porrino, Paola and Cotroneo, Antonino Maria and Galli, Giovanni and Bernardini, Bruno and Corsini, Carla and Cagnin, Annachiara and Barbagallo, Giuseppe and Lunardelli, Maria Lia and Martini, Emilio and Battaglia, Giuseppe and Latella, Raffaele and Cester, Alberto and Carbone, Pasqualina and Cereda, Diletta and Tremolizzo, Lucio and Bottacchi, Edo and Mariani, Claudio and Rapazzini, Piero and Zuliani, Giovanni and Bianchi, Lara and Muti, Ettore and Bottura, Renato and Sgrò, Giovanni and Mandas, Antonella and Serchisu, Luca and Ungar, Andrea and Villani, Daniele and Raimondi, Clara and Mussi, Chiara and Provenzano, Giuseppe and Mari, Daniela and Monacelli, Fiammetta and Incalzi, Raffaele Antonelli and Pluderi, Alice and Bellamoli, Claudio and Terranova, Luciano and Scarpini, Elio and D'Amico, Ferdinando and Cavallini, Maria Chiara and Guerrini, Gianbattista and Scotuzzi, Anna Maria and Chiarello, Antonino and Pilotto, Alberto and Tognini, Sara and Dell'Aquila, Giuseppina and Toigo, Gabriele and Ceschia, Giuliano and Piccinini, Maristella and Fabbo, Andrea and Zoli, Marco and Forti, Paola and Wenter, Christian and Basile, Giorgio and Lasagni, Anna and Padovani, Alessandro and Rozzini, Luca and Vitali, Silvia and Tripi, Gabriele and Avanzi, Stefano and Annoni, Giorgio and Ruotolo, Giovanni and Bonino, Paolo and Marchionni, Niccolo and Fascendini, Sara and Noro, Gabriele and Turco, Renato and Ubezio, Maria C and Serrati, Carlo and Infante, Maria and Gentile, Simona and Pernigotti, Luigi M and Biagini, Carlo A and Canonico, Enzo and Gareri, Pietro and Ceretti, Arcangelo and Castiglia, Rosanna and Storto, Mario Lo and ... and Italian Study Grp Delirium ISGoD and Italian Study Group on Delirium (ISGoD) and on behalf of the Italian Study Group on Delirium (ISGoD)
BMC Medicine, ISSN 1741-7015, 07/2016, Volume 14, Issue 1, p. 106
Journal Article
Journal Article